Demefecil

Demefecil is an original pharmaceutical product developed and marketed by the Russian biopharmaceutical company Petrovax Pharm. It is a zinc-organic coordination complex, specifically bis(1-vinylimidazole) dicarboxylate zinc. The drug is primarily indicated for the treatment of alcohol dependence, including the management of alcohol withdrawal syndrome and the prevention of relapses in patients with chronic alcoholism. Demefecil exhibits a multi-faceted pharmacological profile, functioning as an antioxidant, detoxifier, and immunomodulator with anti-inflammatory properties. It works by reducing the toxic effects of ethanol and its metabolites, such as acetaldehyde, on the body, while also providing antihypoxic effects and stabilizing cell membranes. The product was launched as part of Petrovax's portfolio of original medications following its approval in Russia.

Brand names

DemefecilДемефецил

Other names

Bis(1-vinylimidazole) dicarboxylate zincБис(1-винилимидазол)дикарбоксилат цинка